Emerald Mutual Fund Advisers Trust’s Adamas Pharmaceuticals ADMS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-307,723	Closed	-$1.27M	–	350
2020 Q3	$1.27M	Sell	307,723 -314,326	-51%	-$1.22M	0.06%	156
2020 Q2	$1.59M	Buy	622,049 +25,000	+4%	+$73.5K	0.08%	145
2020 Q1	$1.73M	Buy	597,049 +40,022	+7%	+$179K	0.11%	140
2019 Q4	$2.11M	Sell	557,027 -51,992	-9%	-$249K	0.09%	171
2019 Q3	$3.12M	Sell	609,019 -7,645	-1%	-$47.2K	0.14%	157
2019 Q2	$3.82M	Buy	616,664 +51,345	+9%	+$295K	0.15%	150
2019 Q1	$4.02M	Hold	565,319	–	–	0.16%	158
2018 Q4	$4.83M	Sell	565,319 -61,422	-10%	-$799K	0.23%	140
2018 Q3	$12.5M	Buy	626,741 +76,387	+14%	+$1.79M	0.42%	96
2018 Q2	$14.2M	Buy	550,354 +17,877	+3%	+$495K	0.51%	79
2018 Q1	$12.7M	Buy	532,477 +2,540	+0.5%	+$80.1K	0.5%	70
2017 Q4	$18M	Hold	529,937	–	–	0.71%	46
2017 Q3	$11.2M	Sell	529,937 -41,852	-7%	-$767K	0.47%	76
2017 Q2	$10M	Hold	571,789	–	–	0.44%	81
2017 Q1	$10M	Hold	571,789	–	–	0.46%	75
2016 Q4	$9.66M	Hold	571,789	–	–	0.46%	77
2016 Q3	$9.38M	Buy	571,789 +11,910	+2%	+$181K	0.48%	84
2016 Q2	$8.48M	Buy	559,879 +21,301	+4%	+$351K	0.48%	82
2016 Q1	$7.79M	Buy	538,578 +86,895	+19%	+$1.46M	0.44%	91
2015 Q4	$12.8M	Buy	451,683 +89,371	+25%	+$1.5M	0.68%	59
2015 Q3	$6.07M	Buy	362,312 +45,622	+14%	+$1.04M	0.4%	94
2015 Q2	$8.3M	Sell	316,690 -9,840	-3%	-$191K	0.64%	61
2015 Q1	$5.72M	Buy	326,530 +114,656	+54%	+$1.96M	0.47%	81
2014 Q4	$3.68M	Buy	211,874 +38,654	+22%	+$586K	0.32%	97
2014 Q3	$3.23M	Buy	173,220 +66,999	+63%	+$1.15M	0.31%	103
2014 Q2	$1.94M	Buy	+106,221	New	+$1.9M	0.18%	125